Understanding VTE Risk in RA

Clinicians often face significant challenges when assessing VTE risk in RA among older patients. Rheumatoid arthritis naturally increases the likelihood of vascular complications. Traditional statistical tools, such as the Cox regression model, have served as the clinical standard for decades. However, modern machine learning approaches like the Random Survival Forest (RSF) now offer improved predictive accuracy. A recent study analyzed Medicare data from 3,648 patients to compare these two methodologies effectively.

Comparing RSF and Regularized Cox Models

The research demonstrated that the RSF model achieved a higher C-index of 0.609. In contrast, the regularized Cox regression model scored 0.599. Although this improvement appears modest, the difference reached statistical significance with a p-value of 0.0021. Consequently, these findings suggest that non-linear machine learning models can capture complex interactions between patient variables better than linear alternatives. This is particularly useful when managing the VTE risk in RA after initiating biological or targeted synthetic DMARDs.

Key Predictors of VTE Events

Accurately identifying VTE risk in RA requires a thorough evaluation of specific clinical markers. According to the study, the most influential predictors include:

• History of varicose veins


• Frequency of inpatient and emergency room visits


• High Elixhauser comorbidity scores


• Frequent outpatient healthcare utilization

Moreover, researchers believe that integrating laboratory data and lifestyle factors could further enhance these predictive models. Therefore, clinicians should monitor high-utilization patients closely when starting new targeted therapies.

FAQs about VTE Risk in RA

How does machine learning improve the assessment of VTE risk in RA?

Machine learning models like Random Survival Forest identify non-linear relationships and complex interactions between variables. This capability typically results in higher predictive accuracy than traditional linear regression models.

What clinical factors increase VTE risk in older RA patients?

Key risk factors include a history of varicose veins, high healthcare utilization (such as frequent hospital or ER visits), and a significant burden of comorbidities.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Consult a qualified medical professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Huang Y et al. Predicting the risk of venous thromboembolism events in older adults with rheumatoid arthritis after initiating targeted disease-modifying antirheumatic drugs: a comparison of the random survival forest and regularized cox regression models. Curr Med Res Opin. 2026 May 06. doi: 10.1080/03007995.2026.2666445. PMID: 42090183.

Chung WS, Peng CL, Lin CL, et al. Rheumatoid arthritis and risk of venous thromboembolism: a population-based retrospective cohort study. Ann Rheum Dis. 2014;73(4):734-738.

Oudart F, et al. Risk factors associated with venous thromboembolism in rheumatoid arthritis in clinical practice. Clin Exp Rheumatol. 2025.